PB 118 of 2022
National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 8)
I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.
Dated 30 November 2022
NIKOLAI TSYGANOV
Acting Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
1 Name
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)
1 Name
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 8).
This instrument may also be cited as PB 118 of 2022.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information |
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 December 2022 | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 85B of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)
- Schedule 1- after entry for Atomoxetine
Insert
Azathioprine | Tablet 25 mg | Oral | Imuran | 100 | 9.32 | 13.97 |
| Tablet 50 mg | Oral | Imuran | 100 | 15.88 | 20.53 |
2. Schedule 1- entry for Bisoprolol
Omit
Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Bicor | 28 | 4.90 | 9.76 |
| Tablet containing bisoprolol fumarate 5 mg | Oral | Bicor | 28 | 6.12 | 10.98 |
| Tablet containing bisoprolol fumarate 10 mg | Oral | Bicor | 28 | 7.65 | 12.51 |
Insert
Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Bicor | 28 | 4.90 | 11.17 |
| Tablet containing bisoprolol fumarate 5 mg | Oral | Bicor | 28 | 6.12 | 12.35 |
| Tablet containing bisoprolol fumarate 10 mg | Oral | Bicor | 28 | 7.65 | 13.89 |
3. Schedule 1- after entry for Cefalexin
Insert
Cefuroxime | Tablet 250 mg (as axetil) | Oral | Zinnat | 20 | 6.76 | 12.45 |
4. Schedule 1- entry for Diltiazem
Omit
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Cardizem CD | 30 | 6.25 | 8.02 |
| Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Cardizem CD | 30 | 8.45 | 10.22 |
| Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Cardizem CD | 30 | 11.08 | 12.84 |
Insert
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Cardizem CD | 30 | 6.25 | 8.02 |
| Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Cardizem CD | 30 | 8.45 | 10.22 |
| Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Cardizem CD | 30 | 11.08 | 12.84 |
| Tablet containing diltiazem hydrochloride 60 mg | Oral | Cardizem | 90 | 7.40 | 9.17 |
5. Schedule 1- entry for Esomeprazole
Omit
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium trihydrate) | Oral | Nexium | 30 | 4.00 | 7.17 |
| Tablet (enteric coated) 40 mg (as magnesium trihydrate) | Oral | Nexium | 30 | 6.79 | 9.96 |
Insert
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium trihydrate) | Oral | Nexium | 30 | 4.00 | 10.51 |
| Tablet (enteric coated) 40 mg (as magnesium trihydrate) | Oral | Nexium | 30 | 6.79 | 13.30 |
6. Schedule 1- entry for Flecainide
Omit
Flecainide | Tablet containing flecainide acetate 50 mg | Oral | Tambocor | 60 | 18.14 | 19.56 |
| Tablet containing flecainide acetate 100 mg | Oral | Tambocor | 60 | 22.49 | 23.91 |
Insert
Flecainide | Tablet containing flecainide acetate 50 mg | Oral | Tambocor | 60 | 18.14 | 21.10 |
| Tablet containing flecainide acetate 100 mg | Oral | Tambocor | 60 | 22.49 | 25.46 |
7. Schedule 1- entry for Labetalol
Omit
Labetalol | Tablet containing labetalol hydrochloride 100 mg | Oral | Trandate | 100 | 12.32 | 15.58 |
8. Schedule 1- entry for Lamotrigine
Omit
Lamotrigine | Tablet 25 mg | Oral | Lamictal | 56 | 4.25 | 5.48 |
| Tablet 50 mg | Oral | Lamictal | 56 | 7.08 | 8.18 |
| Tablet 100 mg | Oral | Lamictal | 56 | 11.79 | 12.94 |
| Tablet 200 mg | Oral | Lamictal | 56 | 19.82 | 20.96 |
Insert
Lamotrigine | Tablet 25 mg | Oral | Lamictal | 56 | 4.25 | 8.48 |
| Tablet 50 mg | Oral | Lamictal | 56 | 7.08 | 11.22 |
| Tablet 100 mg | Oral | Lamictal | 56 | 11.79 | 15.93 |
| Tablet 200 mg | Oral | Lamictal | 56 | 19.82 | 23.96 |
9. Schedule 1- entry for Levonorgestrel with ethinylestradiol
Omit
Levonorgestrel with ethinylestradiol | Pack containing 21 tablets 150 micrograms 30 micrograms and 7 inert tablets | Oral | Levlen ED | 4 | 4.75 | 7.84 |
Insert
Levonorgestrel with ethinylestradiol | Pack containing 21 tablets 150 micrograms 30 micrograms and 7 inert tablets | Oral | Levlen ED | 4 | 4.75 | 9.37 |
10. Schedule 1- entry for Metoprolol
Omit
Metoprolol | Tablet containing metoprolol tartrate 50 mg | Oral | Betaloc | 100 | 2.50 | 12.25 |
| Tablet containing metoprolol tartrate 100 mg | Oral | Betaloc | 60 | 2.76 | 12.52 |
Insert
Metoprolol | Tablet containing metoprolol tartrate 50 mg | Oral | Betaloc | 100 | 2.50 | 14.75 |
| Tablet containing metoprolol tartrate 100 mg | Oral | Betaloc | 60 | 2.76 | 14.99 |
11. Schedule 1- entry for Olmesartan with amlodipine
Omit
Olmesartan with amlodipine | Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) | Oral | Sevikar 40/5 | 30 | 6.96 | 9.41 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) | Oral | Sevikar 40/10 | 30 | 7.46 | 9.91 |
Insert
Olmesartan with amlodipine | Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) | Oral | Sevikar 40/5 | 30 | 6.96 | 9.75 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) | Oral | Sevikar 40/10 | 30 | 7.46 | 10.25 |
12. Schedule 1- entry for Olmesartan with amlodipine and hydrochlorothiazide
Omit
Olmesartan with amlodipine and hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 20/5/12.5 | 30 | 5.57 | 8.36 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 40/5/12.5 | 30 | 9.37 | 12.16 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg | Oral | Sevikar HCT 40/5/25 | 30 | 10.83 | 13.62 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 40/10/12.5 | 30 | 9.81 | 12.56 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg | Oral | Sevikar HCT 40/10/25 | 30 | 11.26 | 14.02 |
Insert
Olmesartan with amlodipine and hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 20/5/12.5 | 30 | 5.57 | 8.36 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 40/5/12.5 | 30 | 9.37 | 12.16 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg | Oral | Sevikar HCT 40/5/25 | 30 | 10.83 | 13.62 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 40/10/12.5 | 30 | 9.81 | 12.56 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg | Oral | Sevikar HCT 40/10/25 | 30 | 11.26 | 14.05 |
13. Schedule 1- entry for Quetiapine
Omit
Quetiapine | Tablet 25 mg (as fumarate) | Oral | Seroquel | 60 | 4.00 | 7.42 |
| Tablet (modified release) 50 mg (as fumarate) | Oral | Seroquel XR | 60 | 7.86 | 11.33 |
| Tablet 100 mg (as fumarate) | Oral | Seroquel | 90 | 11.11 | 14.47 |
| Tablet (modified release) 150 mg (as fumarate) | Oral | Seroquel XR | 60 | 11.11 | 18.34 |
| Tablet (modified release) 200 mg (as fumarate) | Oral | Seroquel XR | 60 | 22.87 | 24.32 |
| Tablet 200 mg (as fumarate) | Oral | Seroquel | 60 | 15.14 | 18.50 |
| Tablet (modified release) 300 mg (as fumarate) | Oral | Seroquel XR | 60 | 29.37 | 30.82 |
| Tablet 300 mg (as fumarate) | Oral | Seroquel | 60 | 22.23 | 25.59 |
| Tablet (modified release) 400 mg (as fumarate) | Oral | Seroquel XR | 60 | 40.04 | 41.49 |
Insert
Quetiapine | Tablet 25 mg (as fumarate) | Oral | Seroquel | 60 | 4.00 | 14.33 |
| Tablet (modified release) 50 mg (as fumarate) | Oral | Seroquel XR | 60 | 7.86 | 18.09 |
| Tablet 100 mg (as fumarate) | Oral | Seroquel | 90 | 11.11 | 21.34 |
| Tablet (modified release) 150 mg (as fumarate) | Oral | Seroquel XR | 60 | 11.11 | 27.86 |
| Tablet (modified release) 200 mg (as fumarate) | Oral | Seroquel XR | 60 | 22.87 | 33.10 |
| Tablet 200 mg (as fumarate) | Oral | Seroquel | 60 | 15.14 | 25.37 |
| Tablet (modified release) 300 mg (as fumarate) | Oral | Seroquel XR | 60 | 29.37 | 39.60 |
| Tablet 300 mg (as fumarate) | Oral | Seroquel | 60 | 22.23 | 32.46 |
| Tablet (modified release) 400 mg (as fumarate) | Oral | Seroquel XR | 60 | 40.04 | 50.27 |